First patient dosed with Pyrilutamide (Kintor) Phase III
    Research/Science 1/2/2022

    At a glance
    In this educational post, the primary subjects mentioned are
    💧 Pyrilutamide (topical) 5mg 2x daily
    the tone is 😀 positive with promising results.

    Other terms

    First patient dosed with Pyrilutamide (Kintor) Phase III for hair loss treatment. Pyrilutamide differs from approved treatments as it competes with DHT to bind hair follicles, potentially reducing side effects.
    View this post in the Community →

    Similar Community Posts Join

    5 / 744 results

    Related Research

    6 / 8 results